These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25153380)

  • 1. KLKs and their hormone-like signaling actions: a new life for the PSA-KLK family.
    Hollenberg MD
    Biol Chem; 2014 Sep; 395(9):915-29. PubMed ID: 25153380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier.
    Oikonomopoulou K; Diamandis EP; Hollenberg MD
    Biol Chem; 2010 Apr; 391(4):299-310. PubMed ID: 20180639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
    Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD
    Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
    Scorilas A; Mavridis K
    Expert Rev Mol Diagn; 2014 Jul; 14(6):713-22. PubMed ID: 24927162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
    Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
    Avgeris M; Scorilas A
    Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.
    Veveris-Lowe TL; Kruger SJ; Walsh T; Gardiner RA; Clements JA
    Semin Thromb Hemost; 2007 Feb; 33(1):87-99. PubMed ID: 17253195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer.
    Figueroa CD; Molina L; Bhoola KD; Ehrenfeld P
    Biol Chem; 2018 Sep; 399(9):937-957. PubMed ID: 29885274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary history of tissue kallikreins.
    Pavlopoulou A; Pampalakis G; Michalopoulos I; Sotiropoulou G
    PLoS One; 2010 Nov; 5(11):e13781. PubMed ID: 21072173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation and activity of glycosylated KLKs 3, 4 and 11.
    Guo S; Briza P; Magdolen V; Brandstetter H; Goettig P
    Biol Chem; 2018 Sep; 399(9):1009-1022. PubMed ID: 29975661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.
    Pampalakis G; Sotiropoulou G
    Biochim Biophys Acta; 2007 Sep; 1776(1):22-31. PubMed ID: 17629406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallikreins as biomarkers for prostate cancer.
    Hong SK
    Biomed Res Int; 2014; 2014():526341. PubMed ID: 24809052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate Cancer.
    Lovell S; Zhang L; Kryza T; Neodo A; Bock N; De Vita E; Williams ED; Engelsberger E; Xu C; Bakker AT; Maneiro M; Tanaka RJ; Bevan CL; Clements JA; Tate EW
    J Am Chem Soc; 2021 Jun; 143(23):8911-8924. PubMed ID: 34085829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers.
    Emami N; Diamandis EP
    Clin Chem; 2008 Oct; 54(10):1600-7. PubMed ID: 18687738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of membrane-bound proteins and receptor systems: a link between tissue kallikrein and the KLK-related peptidases.
    Dong Y; Harrington BS; Adams MN; Wortmann A; Stephenson SA; Lisle J; Herington A; Hooper JD; Clements JA
    Biol Chem; 2014 Sep; 395(9):977-90. PubMed ID: 24854540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinases as hormones: targets and mechanisms for proteolytic signaling.
    Hansen KK; Oikonomopoulou K; Baruch A; Ramachandran R; Beck P; Diamandis EP; Hollenberg MD
    Biol Chem; 2008 Aug; 389(8):971-82. PubMed ID: 18979623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLK-targeted Therapies for Prostate Cancer.
    Hannu K; Johanna M; Ulf-Håkan S
    EJIFCC; 2014 Sep; 25(2):207-18. PubMed ID: 27683469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting kallikrein-related peptidases in prostate cancer.
    Mavridis K; Avgeris M; Scorilas A
    Expert Opin Ther Targets; 2014 Apr; 18(4):365-83. PubMed ID: 24571737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the kallikrein-related peptidases for drug development.
    Sotiropoulou G; Pampalakis G
    Trends Pharmacol Sci; 2012 Dec; 33(12):623-34. PubMed ID: 23089221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?
    Tan OL; Whitbread AK; Clements JA; Dong Y
    Biol Chem; 2006 Jun; 387(6):697-705. PubMed ID: 16800730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.